Terms of the transaction were not disclosed.

The business being acquired comprises catheter-based endovascular and surface temperature management technologies, developed to improve outcomes for patients with a variety of temperature management-related needs.

InnerCool management business includes products such as RTx Endovascular System, Accutrol Catheter, CoolRepeat and STx Surface Cooling Systems.

All the systems have regulatory approval in the US, said ZOLL

ZOLL Medical president James Palazzolo said: "The combination of InnerCool with ZOLL’s existing temperature management technologies expands ZOLL’s position as the leading provider of high technology systems for precise temperature management.

"This underscores our commitment to provide a wide variety of clinical temperature therapies based on physician preference and clinical judgment."

The acquired business will be incorporated into ZOLL’s temperature management business in San Jose, California.